Birchview Capital as of Sept. 30, 2023
Portfolio Holdings for Birchview Capital
Birchview Capital holds 51 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 35.3 | $42M | 716k | 58.04 | |
| Biodesix (BDSX) | 7.5 | $8.8M | 5.3M | 1.65 | |
| Neurocrine Biosciences (NBIX) | 7.4 | $8.7M | 77k | 112.50 | |
| Prothena Corp SHS (PRTA) | 6.9 | $8.2M | 170k | 48.25 | |
| ACADIA Pharmaceuticals (ACAD) | 4.3 | $5.0M | 240k | 20.84 | |
| Quidel Corporation | 4.0 | $4.8M | 65k | 73.04 | |
| Encana Corporation (OVV) | 3.4 | $4.0M | 84k | 47.57 | |
| ImmunoGen | 2.6 | $3.0M | 190k | 15.87 | |
| United Therapeutics Corporation (UTHR) | 2.1 | $2.5M | 11k | 225.87 | |
| Aziyo Biologics (ELUT) | 2.0 | $2.4M | 1.7M | 1.43 | |
| Harrow Health (HROW) | 1.8 | $2.2M | 150k | 14.37 | |
| Phreesia (PHR) | 1.3 | $1.5M | 83k | 18.68 | |
| Alkermes SHS (ALKS) | 1.2 | $1.4M | 50k | 28.01 | |
| Bluebird Bio | 1.2 | $1.4M | 455k | 3.04 | |
| Corcept Therapeutics Incorporated (CORT) | 1.2 | $1.4M | 50k | 27.25 | |
| Masimo Corporation (MASI) | 1.1 | $1.3M | 15k | 87.68 | |
| Foghorn Therapeutics (FHTX) | 1.1 | $1.3M | 265k | 5.00 | |
| Accelr8 Technology | 1.1 | $1.3M | 225k | 5.75 | |
| Inhibrx | 1.1 | $1.3M | 70k | 18.35 | |
| Equitrans Midstream Corp (ETRN) | 1.1 | $1.2M | 133k | 9.37 | |
| Alphatec Holdings (ATEC) | 0.9 | $1.0M | 80k | 12.97 | |
| Ventyx Biosciences (VTYX) | 0.8 | $917k | 26k | 34.73 | |
| Pioneer Natural Resources | 0.7 | $872k | 3.8k | 229.55 | |
| 10x Genomics Cl A Com (TXG) | 0.7 | $866k | 21k | 41.25 | |
| Axogen (AXGN) | 0.7 | $865k | 173k | 5.00 | |
| Karyopharm Therapeutics | 0.7 | $766k | 572k | 1.34 | |
| Cytokinetics (CYTK) | 0.6 | $737k | 25k | 29.46 | |
| Travere Therapeutics (TVTX) | 0.6 | $733k | 82k | 8.94 | |
| Docgo (DCGO) | 0.6 | $693k | 130k | 5.33 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $685k | 18k | 38.04 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $634k | 38k | 16.68 | |
| Silk Road Medical Inc Common | 0.5 | $619k | 41k | 14.99 | |
| Progyny (PGNY) | 0.5 | $612k | 18k | 34.02 | |
| Kiniksa Pharmaceuticals | 0.4 | $521k | 30k | 17.37 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $385k | 40k | 9.63 | |
| Halozyme Therapeutics (HALO) | 0.3 | $382k | 10k | 38.20 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $342k | 10k | 34.16 | |
| Amicus Therapeutics (FOLD) | 0.3 | $341k | 28k | 12.16 | |
| Stoke Therapeutics (STOK) | 0.3 | $335k | 85k | 3.94 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $303k | 2.5k | 121.22 | |
| Arvinas Ord (ARVN) | 0.3 | $295k | 15k | 19.64 | |
| Xencor (XNCR) | 0.2 | $248k | 12k | 20.15 | |
| 2seventy Bio | 0.2 | $235k | 60k | 3.92 | |
| Cullinan Oncology (CGEM) | 0.2 | $227k | 25k | 9.05 | |
| Keros Therapeutics (KROS) | 0.2 | $223k | 7.0k | 31.88 | |
| Gossamer Bio (GOSS) | 0.1 | $174k | 209k | 0.83 | |
| G1 Therapeutics | 0.1 | $173k | 120k | 1.44 | |
| Inflarx Nv (IFRX) | 0.1 | $149k | 50k | 2.98 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $142k | 20k | 7.08 | |
| Nektar Therapeutics | 0.0 | $17k | 28k | 0.60 | |
| Yield10 Bioscience | 0.0 | $6.1k | 19k | 0.33 |
